40 computer-algorithm-"Fraunhofer-Gesellschaft" Postdoctoral positions at The Ohio State University
Sort by
Refine Your Search
-
references, and one or more writing samples (published or in press). Materials should be attached to the application and sent electronically to Dr. Raeshan Davis, Research Scientist and HHMI Program Manager
-
with statistical modeling (ideally Bayesian statistics) • Proficiency in Fortran, R, Python, Matlab, or ideally other common languages (e.g., C/C++) Strong computational skills Strong oral and written
-
. Previous experience in clinical research is desirable, particularly patient-oriented research. Additional Information: The OSUCCC – James is the only cancer program in the United States that features a
-
-employment physical including a drug screen. Additional Information: The focus of the NIH research program is on “Mechanotransduction and Mechanical Stress induced Postoperative ileus” (POI). The goal is to
-
member of the Oncology Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01
-
: PhD in social science, data science, computer science, information systems, environmental science, ecology, or related field. Demonstrated ability to conduct independent research, as evidenced by peer
-
software program (e.g., R, STATA) Demonstrated experience accessing, preparing, and analyzing secondary data Strong interpersonal and communication skills, with the ability to collaborate effectively with
-
/ Statistical Genetics or closely related program. Required Qualifications Ph.D. degree in bioinformatics, statistical genetics, biostatistics, or a closely aligned quantitative area. Candidate is expected
-
of highly specialized mass spectrometry assays to support immuno-oncology and cancer biology research initiatives, collaborating closely with a multidisciplinary team of computational biologists
-
) Founding member of the Oncology Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant